Pacira BioSciences (PCRX) Other Non Operating Income (2010 - 2026)

Pacira BioSciences' Other Non Operating Income history runs 17 years deep, the most recent figure standing at -$135000.0 for Q1 2026.

• In Q1 2026, Other Non Operating Income fell 103.07% year-over-year to -$135000.0; the TTM figure through Mar 2026 stood at -$417000.0 (down 110.35% YoY), while the FY2025 annual figure was -$6.6 million, down 1674.8% from the prior year.
• Other Non Operating Income was -$135000.0 for Q1 2026 at Pacira BioSciences, up from -$172000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $11.4 million in Q4 2022 to a low of -$16.9 million in Q1 2023.
• Historically, Other Non Operating Income has averaged -$1.6 million across 5 years, with a median of -$165500.0 in 2024.
• The sharpest annual moves came in 2022 and 2023: Other Non Operating Income jumped 17325.76% in 2022, then slumped 242.71% in 2023.
• A 5-year view of Other Non Operating Income shows it stood at $11.4 million in 2022, then plunged by 242.71% to -$16.2 million in 2023, then jumped by 51.37% to -$7.9 million in 2024, then jumped by 97.82% to -$172000.0 in 2025, then advanced by 21.51% to -$135000.0 in 2026.
• The last three Other Non Operating Income figures came in at -$135000.0 (Q1 2026), -$172000.0 (Q4 2025), and -$110000.0 (Q3 2025), per Business Quant data.